The Association between Parathyroid Hormone Levels and the Cardiorenal Metabolic Syndrome in Non-Diabetic Chronic Kidney Disease
- PMID: 22258399
- PMCID: PMC3101512
- DOI: 10.1159/000327149
The Association between Parathyroid Hormone Levels and the Cardiorenal Metabolic Syndrome in Non-Diabetic Chronic Kidney Disease
Abstract
Aims: The relationship between parathyroid hormone (PTH) and the cardiorenal metabolic syndrome was examined among non-diabetic persons with chronic kidney disease (CKD).
Methods: In a cross-sectional analysis, the relationship between PTH levels and the cardiorenal metabolic syndrome was investigated in 3,215 non-diabetic participants in the National Kidney Foundation-Kidney Early Evaluation Program (KEEP 2.0) found to have CKD (eGFR <60 ml/min/1.73 m2).
Results: In unadjusted analyses, the prevalence of the cardiorenal metabolic syndrome increased along increasing PTH quartiles (31.7, 33.8, 37.3, and 48.7%, respectively, p for trend <0.0001). After multivariate adjustment, as compared to the first PTH quartile, odds of the cardiorenal metabolic syndrome were 16% (p = 0.18), 35% (p = 0.006), and 80% (p < 0.0001) higher for the second, third, and fourth quartiles, respectively. When taken as a continuous predictor, each standard deviation increase of natural log transformed PTH was associated with 26% (p < 0.0001) higher odds of the cardiorenal metabolic syndrome. The association of PTH with the cardiorenal metabolic syndrome was not modified by age or gender (p for interaction was not significant for both modifiers).
Conclusions: Among an outpatient non-diabetic population with CKD, higher PTH levels were associated with a higher prevalence of the cardiorenal metabolic syndrome.
Keywords: Chronic kidney disease; Hyperparathyroidism; KEEP; Metabolic syndrome.
© 2011 S. Karger AG, Basel.
Figures
Similar articles
-
The Association between Parathyroid Hormone Levels and Hemoglobin in Diabetic and Nondiabetic Participants in the National Kidney Foundation's Kidney Early Evaluation Program.Cardiorenal Med. 2013 Jul;3(2):120-127. doi: 10.1159/000351229. Epub 2013 Jun 1. Cardiorenal Med. 2013. PMID: 23922552 Free PMC article.
-
Obesity is associated with increased parathyroid hormone levels independent of glomerular filtration rate in chronic kidney disease.Metabolism. 2010 Mar;59(3):385-9. doi: 10.1016/j.metabol.2009.08.007. Epub 2009 Oct 2. Metabolism. 2010. PMID: 19800639
-
Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).Am J Kidney Dis. 2009 Apr;53(4 Suppl 4):S3-10. doi: 10.1053/j.ajkd.2008.11.029. Am J Kidney Dis. 2009. PMID: 19285609
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism in stage 5 chronic kidney disease.Kidney Int Suppl. 2005 Jul;(96):S24-8. doi: 10.1111/j.1523-1755.2005.00451.x. Kidney Int Suppl. 2005. PMID: 15954947 Review.
Cited by
-
The association of parathyroid hormone with ESRD and pre-ESRD mortality in the Kidney Early Evaluation Program.J Clin Endocrinol Metab. 2012 Dec;97(12):4414-21. doi: 10.1210/jc.2012-2001. Epub 2012 Oct 12. J Clin Endocrinol Metab. 2012. PMID: 23066118 Free PMC article.
-
Blood and Urinary Biomarkers of Antipsychotic-Induced Metabolic Syndrome.Metabolites. 2022 Aug 5;12(8):726. doi: 10.3390/metabo12080726. Metabolites. 2022. PMID: 36005598 Free PMC article. Review.
-
The Association between Parathyroid Hormone Levels and Hemoglobin in Diabetic and Nondiabetic Participants in the National Kidney Foundation's Kidney Early Evaluation Program.Cardiorenal Med. 2013 Jul;3(2):120-127. doi: 10.1159/000351229. Epub 2013 Jun 1. Cardiorenal Med. 2013. PMID: 23922552 Free PMC article.
-
Clinical characterization and prognostic implications of metabolic syndrome in patients undergoing peritoneal dialysis at a Chinese center.J Int Med Res. 2019 Nov;47(11):5573-5583. doi: 10.1177/0300060519875335. Epub 2019 Sep 18. J Int Med Res. 2019. PMID: 31533550 Free PMC article.
-
Associations between serum-intact parathyroid hormone, serum 25-hydroxyvitamin D, oral vitamin D analogs and metabolic syndrome in peritoneal dialysis patients: a multi-center cross-sectional study.Perit Dial Int. 2014 Jun;34(4):447-55. doi: 10.3747/pdi.2013.00001. Epub 2014 Feb 4. Perit Dial Int. 2014. PMID: 24497582 Free PMC article.
References
-
- Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med. 2004;140:167–174. - PubMed
-
- Mak RH. Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. Kidney Int. 1992;41:1049–1054. - PubMed
-
- Mak RH. Correction of anemia by erythropoietin reverses insulin resistance and hyperinsulinemia in uremia. Am J Physiol Renal Physiol. 1996;270:F839–F844. - PubMed
-
- Mak RH, Turner C, Haycock GB, Chantler C. Secondary hyperparathyroidism and glucose intolerance in children with uremia. Kidney Int Suppl. 1983;16:S128–S133. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous